| Literature DB >> 34122857 |
Shuyue Zhang1, Mark D Greenhalgh1, Alexandra M Z Slawin1, Andrew D Smith1.
Abstract
An isothiourea-catalysed enantioselective synthesis of novel tetrahydroindolizine derivatives is reported through a one-pot tandem sequential process. The application of 2-(pyrrol-1-yl)acetic acid in combination with either a trifluoromethyl enone or an α-keto-β,γ-unsaturated ester in an enantioselective Michael addition-lactonisation process, followed by in situ ring-opening and cyclisation, led to a range of 24 tetrahydroindolizine derivatives containing three stereocentres in up to >95 : 5 dr and >99 : 1 er. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34122857 PMCID: PMC8152628 DOI: 10.1039/d0sc00432d
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Tetrahydroindolizine cores present within natural products and bioactive compounds.
Scheme 1Applications of isothiouronium enolate catalysis in Michael addition–lactonisation/lactamisation processes.
Reaction optimisation I: selectivity for formation of dihydropyranone 8
|
| |||||||
|---|---|---|---|---|---|---|---|
| Entry | Solvent | Catalyst | Conversion (%) | Ratio | Yield | dr | er |
| 1 | MeCN |
| 100 | 20 : 15 : 65 | — | — | |
| 2 | DMF |
| 100 | 0 : 0 : 100 |
| 80 : 20 | |
| 3 | CH2Cl2 |
| 100 | 20 : 50 : 30 | |||
| 4 | CH2Cl2 |
| 95 | 50 : 50 : 0 |
| 95 : 5 | 96 : 4 |
| 5 | Et2O |
| 90 | 75 : 15 : 10 | |||
| 6 | MTBE |
| 63 | 65 : 30 : 5 | |||
| 7 | CPME |
| 97 | 85 : 15 : 0 |
| 80 : 20 | 94 : 6 |
| 8 | CPME |
| 68 | 60 : 15 : 25 | |||
| 9 | CPME |
| 70 | 60 : 15 : 25 | |||
| 10 | EtOAc |
| 90 | 75 : 5 : 20 | |||
| 11 |
|
| 98 | 90 : 5 : 5 |
| 80 : 20 | 95 : 5 |
Determined by 1H NMR spectroscopic analysis of the crude reaction product mixture, with values rounded to nearest 5.
Isolated yield of specified product.
Determined by chiral stationary phase HPLC analysis.
Reaction conducted at −60 °C, DMF = dimethylformamide, MTBE = methyl t-butyl ether, CPME = cyclopentyl methyl ether.
Scheme 2Control experiments.
Reaction optimisation II: formation of tetrahydroindolizine 14
|
| ||||||
|---|---|---|---|---|---|---|
| Entry | Solvent | Temp. | Yield (%) | dr | ermaj | ermin |
| 1 | CPME | r.t. | 88 | 75 : 25 | 93 : 7 | 81 : 19 |
| 2 |
| r.t. | 71 | 70 : 30 | 97 : 3 | 68 : 32 |
| 3 | CPME | −40 °C | 76 | 90 : 10 | 94 : 6 | 92 : 8 |
| 4 |
| −40 °C | 83 | 90 : 10 | 98 : 2 | 96 : 4 |
Determined by 1H and 19F NMR spectroscopic analysis of the crude reaction product mixture, with values rounded to nearest 5.
Determined by chiral stationary phase HPLC analysis. CPME = cyclopentyl methyl ether. DMAP = 4-(dimethylamino)pyridine.
Fig. 2Rationale for configuration of the major diastereoisomer of tetrahydroindolizine.
Reaction scope I: trifluoromethyl enone Michael acceptorsa
|
|
dr determined by 1H and 19F NMR spectroscopic analysis of the crude reaction product mixture, with values rounded to nearest 5; er determined by chiral stationary phase HPLC analysis.
ND = could not be determined.
Scheme 3Initial optimisation using α-keto-β,γ-unsaturated ester 27.
Scheme 4Optimisation of ring-opening–cyclisation process using amines.
Reaction scope II: α-keto-β,γ-unsaturated ester Michael acceptorsa
|
|
dr determined by 1H NMR spectroscopic analysis of the crude reaction product mixture, with values rounded to nearest 5; er determined by chiral stationary phase HPLC analysis.
CH2Cl2 used as solvent due to low solubility of α-keto-β,γ-unsaturated ester in MeCN.
Scheme 5Proposed mechanism.